Source link : https://newshealth.biz/health-news/first-drug-approved-for-ultra-rare-kidney-disease/
(MedPage Today) — The FDA approved iptacopan (Fabhalta) as the first treatment to reduce proteinuria in adults with complement 3 glomerulopathy (C3G), the agency announced Thursday. “C3G is a debilitating disease often affecting young people… Source link : https://www.medpagetoday.com/nephrology/generalnephrology/114779 Author : Publish date : 2025-03-21 19:50:00 Copyright for syndicated content belongs to the linked Source.
The post First Drug Approved for Ultra-Rare Kidney Disease first appeared on News Health.
Author : News Health
Publish date : 2025-03-21 19:50:00
Copyright for syndicated content belongs to the linked Source.